VUMC to lead national study to treat severe COVID complications
May 6, 2021
https://news.vumc.org/2021/05/06/vumc-to-lead-national-study-to-treat-severe-covid-complications/
The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19.
VUMC aids national effort to repurpose drugs for COVID-19
April 19, 2021
https://news.vumc.org/2021/04/19/vumc-aids-national-effort-to-repurpose-drugs-for-covid-19/
Vanderbilt University Medical Center (VUMC) has been named Data Coordinating Center (DCC) for a nationwide platform of studies aimed at “repurposing” existing drugs to treat mild to moderate symptoms of COVID-19.
VICTR named to key role to streamline COVID-19 research response
June 24, 2020
https://news.vumc.org/2020/06/24/victr-named-to-key-role-to-streamline-covid-19-research-response/
The Vanderbilt Institute for Clinical and Translational Research (VICTR) and RTI International, a non-profit clinical research organization based in North Carolina, have been named Administrative Coordinating Center (ACC) of a national effort